Scholarly Research Exchange
Volume 2009 (2009), Article ID 786451, 3 pages
doi:10.3814/2009/786451
Case Report

Severe Invasive Group A Streptococcal Disease with Rhabdomyolysis but without Evidence of Shock or Local Myositis

Arthur Okere,1 David Schwartz,1 Philip Tierno,2 Patrick Schlievert,3 and Randa Hamadeh1

1Department of Medicine, New York University Medical Center, New York, NY 10016, USA
2Laboratory Medicine, New York University Medical Center, New York, NY 10016, USA
3Department of Microbiology, University of Minnesota, Minneapolis, MN 55812, USA

Received 11 February 2009; Accepted 12 March 2009

Copyright © 2009 Arthur Okere et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Adams, S. Gudmundsson, D. E. Yocum, R. C. Haselby, W. A. Craig, and W. R. Sundstrom, “Streptococcal myositis,” Archives of Internal Medicine, vol. 145, no. 6, pp. 1020–1023, 1985. View at Publisher · View at Google Scholar
  2. K. Belani, P. Schlievert, E. L. Kaplan, and P. Ferrieri, “Association of exotoxin-producing group A streptococci and severe disease in children,” Pediatric Infectious Disease Journal, vol. 10, no. 5, pp. 351–354, 1991.
  3. P. Schlievert, personal communication, Department of Microbiology, University of Minnesota.
  4. A. L. Bisno and D. L. Stevens, “Streptococcal infections in skin and soft tissues,” The New England Journal of Medicine, vol. 334, no. 4, pp. 240–245, 1996.
  5. P. Schlievert, “Role of superantigens in human disease,” Journal of Infectious Diseases, vol. 167, no. 5, pp. 997–1002, 1993.
  6. B. L. Kotzin, “Superantigens and their role in disease,” Hospital Practice, vol. 29, no. 11, pp. 59–63, 68–70, 1994.
  7. “Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. The Working Group on Severe Streptococcal Infections,” The Journal of the American Medical Association, vol. 269, no. 3, pp. 390–391, 1993. View at Publisher · View at Google Scholar
  8. A. R. Hauser, D. L. Stevens, E. L. Kaplan, and P. Schlievert, “Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome,” Journal of Clinical Microbiology, vol. 29, no. 8, pp. 1562–1567, 1991.
  9. D. R. Johnson, D. L. Stevens, and E. L. Kaplan, “Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis,” Journal of Infectious Diseases, vol. 166, no. 2, pp. 374–382, 1992.
  10. J. M. Musser, A. R. Hauser, M. H. Kim, P. Schlievert, K. Nelson, and R. K. Selander, “Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 7, pp. 2668–2672, 1991. View at Publisher · View at Google Scholar
  11. B. Schwartz, R. R. Facklam, and R. F. Breiman, “Changing epidemiology of group A streptococcal infection in the USA,” The Lancet, vol. 336, no. 8724, pp. 1167–1171, 1990. View at Publisher · View at Google Scholar
  12. D. L. Stevens, M. H. Tanner, J. Winship, et al., “Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome,” The New England Journal of Medicine, vol. 321, pp. 1–7, 1989.
  13. E. T. Gaworzewska and G. Coleman, “Correspondence: group A streptococcal infections and a toxic shock-like syndrome,” The New England Journal of Medicine, vol. 321, p. 1546, 1989.
  14. B. Stegmayr, S. Björck, S. Holm, J. Nisell, A. Rydvall, and B. Settergren, “Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects,” Scandinavian Journal of Infectious Diseases, vol. 24, no. 5, pp. 589–597, 1992. View at Publisher · View at Google Scholar
  15. J. A. Mollick, G. G. Miller, J. M. Musser, R. G. Cook, D. Grossman, and R. R. Rich, “A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C,” The Journal of Clinical Investigation, vol. 92, no. 2, pp. 710–719, 1993. View at Publisher · View at Google Scholar · View at PubMed
  16. M. Iwasaki, H. Igarashi, Y. Hinuma, and T. Yutsudo, “Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor,” FEBS Letters, vol. 331, no. 1-2, pp. 187–192, 1993. View at Publisher · View at Google Scholar
  17. A. Norrby-Teglund, D. Newton, M. Kotb, S. E. Holm, and M. Norgren, “Superantigenic properties of the group A streptococcal exotoxin SpeF (MF),” Infection and Immunity, vol. 62, no. 12, pp. 5227–5233, 1994.
  18. G. A. Bohach, D. J. Fast, R. D. Nelson, and P. Schlievert, “Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses,” Critical Reviews in Microbiology, vol. 17, no. 4, pp. 251–272, 1990. View at Publisher · View at Google Scholar
  19. D. L. Murray, D. H. Ohlendorf, and P. Schlievert, “Staphylococcal and streptococcal superantigens: their role in human disease,” ASM News, vol. 61, no. 5, pp. 229–235, 1995.
  20. J. Kuby, Immunology, W. H. Freeman, New York, NY, USA, 2nd edition, 1994.
  21. V. Hríbalová, “Streptococcus pyogenes and the toxic shock syndrome,” Annals of Internal Medicine, vol. 108, no. 5, p. 772, 1988.